TERI DEVINE: Open Payments
NPI 1629213509 · DAVENPORT, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,109 in 57 payments from 23 companies in 2025. Trend: 2023 $961 · 2024 $816 · 2025 $1,109
Food & beverage: $1,004Education: $105
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $201 |
| Teva Pharmaceuticals USA, Inc. | 9 | $146 |
| Novartis Pharmaceuticals Corporation | 4 | $106 |
| ARGENX US, INC. | 3 | $91 |
| PFIZER INC. | 4 | $79 |
| Neurocrine BioSciences, Inc. | 2 | $48 |
| CSL Behring | 2 | $46 |
| ACADIA Pharmaceuticals Inc | 2 | $44 |
| MDD US Operations, LLC | 2 | $40 |
| JAZZ PHARMACEUTICALS INC. | 2 | $38 |
Products named: KESIMPTA, NURTEC ODT, VYVGART HYTRULO, BOTOX, AUSTEDO XR, QULIPTA, INGREZZA, Hizentra.
Industry payments across IA — which companies pay providers there.
